Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ImpediMed.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Inoviq soars on clinical data for breast cancer test
Health & Biotech
ScoPo’s Powerplays: ASX health stocks… could be worse
Health & Biotech
ASX biotechs are looking up, and the FDA breakthroughs are starting to flow
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall as investors fail to reward good news
News
Closing Bell: It’s a win for the ASX, loss for the newly unemployed as Aussie jobless rate rises
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise as Proteomics inks Sonic deal
Health & Biotech
ScoPo’s (he’s back) Powerplays: ASX health stocks fall, Volpara ‘elephants’ strategy pays off
Health & Biotech
ASX Health Stocks: US FDA approves ImpediMed’s newly designed bioimpedance thingy
News
Market Highlights: US bank stocks in shambles, Apple’s earnings, and 5 ASX small caps to watch
News
Rise and Shine: Everything you need to know about the ASX on Thursday
News
CLOSING BELL: Despite another charge on gold, the ASX has limped to a -0.08% close
Health & Biotech
ScoPo’s (actually Iain’s) Powerplays: ASX health stocks fall, Neuren’s DAYBUE drug officially rolling out in US
News
ASX March Winners: Gold stocks the beneficiary in turbulent month for investors
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps and IPOs Weekly Wrap: If you’re gonna snap a 7-week losing streak, this is how to do it.
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise, ImpediMed surges 99% on NCCN guidelines update
News